Superior vena cava syndrome treated by percutaneous transluminal balloon angioplasty

Walpole, Howard T.; Lovett, K; Chuang, Vincent P.; West, Roger A.; Clements, Stephen D.

doi:10.1016/0002-8703(88)90025-7

Cited by 20 publications

(9 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical bypass of superior vena cava [26,27] or percutaneous transluminal balloon angioplasty [28] have been shown to have some rules in management of SVCO due to benign or malignant diseases. However, symptomatic therapy using corticosteroids and diuretics has never been demonstrated to be beneficial and therefore was not used in our patients.…”

Section: Discussionmentioning

confidence: 99%

Superior Vena Caval Obstruction: King Khalid University Hospital Experience

Ajarim

1992

Ann Saudi Med

View full text Add to dashboard Cite

A five year experience, in 21 patients with superior vena caval obstruction (SVCO) was reviewed. SVCO was due to benign conditions in four patients (19%) and malignant tumors in 17 patients (81%). Lymphoma and lung cancer were the most common causes encountered. The most common symptoms and signs were facial swelling, shortness of breath, jugular venous distention, swelling of face and arms, and engorgement of thoracic veins. Benign disorders had a longer duration of symptoms before presentation and required longer time to make the diagnosis than in malignant disorders. No serious complications resulted from the superior vena cava obstruction itself or the investigative procedures leading to the diagnosis. Prognosis and response to treatment were dependent on the underlying cause of SVCO. Chemotherapy was effective in induction of complete regression of SVCO in the majority of patients with underlying malignant disorders. We conclude that SVCO should be approached invasively for diagnosis and tissue diagnosis of the underlying disorder should dictate the appropriate therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Superior Vena Caval Obstruction: King Khalid University Hospital Experience

Ajarim

1992

Ann Saudi Med

View full text Add to dashboard Cite

show abstract

“…Walpole et al described a 71-year-old man with SVC obstruction due to crossing pacemaker leads, successfully treated with two sessions of angioplasty in a 6-day period. Follow-up, 9 months later, documented a patent SVC [25].…”

Section: Svcmentioning

confidence: 97%

“…Obstruction of the superior vena cava (SVC), innominate, or subclavian vein is usually secondary to the presence of pacemaker leads, external compression by mediastinal tumor or thrombosis, and fibrosis due to recurrent or prolonged cannulation for endomyocardial biopsy or central venous access [1,2,8,9,14,22,25]. In children, obstruction of the SVC is often seen after the repair of congenital heart disease such as anomalous pulmonary venous return, atrial switch procedure for transposition of the great arteries, or SVC to pulmonary artery anastomosis [3,10,21].…”

Section: Svcmentioning

confidence: 99%

See 1 more Smart Citation

Transcatheter Management of Venous Stenosis

Wax

Rocchini

1998

Pediatr Cardiol

View full text Add to dashboard Cite

“…Finally, newer approaches have been attempted such as balloon angioplasty and stent placement although their ultimate role is not yet defined. 89,90…”

Section: Fig 1 Diffuse L a R G Cell Lymphoma Producing Superior Vena mentioning

confidence: 99%

Cardiac manifestations of noncardiac tumors. Part I: Direct effects

Weinberg

Conces

Waller

1989

Clinical Cardiology

View full text Add to dashboard Cite

Summary: Cardiac manifestations of secondary tumors of the heart may exert their effects directly by endocardial, myocardial, epicardial, or cavitary deposits (metastatic lesions), indirectly via tumor products such as in carcinoma, or mediated by therapy (chemotherapy, radiation) to treat the primary neoplasm. Part I of this review summarizes the frequency of metastatic cardiac involvement by various tumors and discusses pencardial manifestations (effusion, tamponade, constriction), one of the most common consequences of direct cardiac involvement by secondary tumors.

show abstract

Superior vena cava syndrome treated by percutaneous transluminal balloon angioplasty

Cited by 20 publications

References 6 publications

Superior Vena Caval Obstruction: King Khalid University Hospital Experience

Superior Vena Caval Obstruction: King Khalid University Hospital Experience

Transcatheter Management of Venous Stenosis

Cardiac manifestations of noncardiac tumors. Part I: Direct effects

Contact Info

Product

Resources

About